A study of more than 750,000 pregnancies found early exposure to Ozempic, Wegovy and similar drugs was not linked to more complications when used for weight loss, but was linked to a higher risk of premature birth when prescribed for diabetes; the researchers caution that safety in pregnancy remains uncertain. ScienceDaily
ScienceDailyStudy of 750,000 pregnancies reveals a surprising twist about Ozempic and WegovyA study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference sug
If diabetes itself may be driving the premature-birth risk, how should studies separate the drug from the condition?
Micwyn· CultureAI moved this conversation to GLP-1 Drugs . Reason: Filed into a square started automatically for this tag.
· details or appeal